Efficacy of Medical Ozone for Treatment of Chronic Musculoskeletal Pain with Abnormal Mitochondrial Redox State
Not Applicable
- Conditions
- Musculoskeletal Diseases
- Registration Number
- PACTR201908620943471
- Lead Sponsor
- Department of Anesthesia and Pain Management Medical Research Institute Alexandria University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Patients with chronic musculoskeletal pain for more than 6 months.
Patients with 4 – 8 trigger points
VAS more than 4.
Serum lactate/pyruvate ratio of more than 10 / 1.
Both sexes between 20-60 years.
Exclusion Criteria
Bleeding tendency.
Glucose 6 phosphate deficiency.
Skin infection at the site of injection.
Systemic infection.
Hypersensitivity to the used medication
Diabetic patients
Recent history of steroid therapy in the last three months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Analogue Scale
- Secondary Outcome Measures
Name Time Method actate / Pyruvate ratio